Advanced Enzyme Technologies Limited — Others, 27-03-2025: ESOP/ESOS/ESPS

The Nomination and Remuneration Committee of Advanced Enzyme Technologies has approved the grant of 5,12,500 stock options under the Employee Stock Option Scheme 2022. These options correlate to the same number of equity shares, with a pricing structure that includes discounts based on the market price. The options will not vest for one year and may be exercised over a maximum of five years. This move could enhance employee motivation and retention, reflecting a strong commitment to talent management. Investors may view this positively as it aligns employee interests with shareholder value, potentially driving long-term growth.